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BACKGROUND: Coronary microvascular dysfunction (MVD) is defined by impaired 
flow augmentation in response to a pharmacological vasodilator in the presence of 
nonobstructive coronary artery disease. It is unknown whether diminished coronary 
vasodilator response correlates with abnormal exercise physiology or inducible 
myocardial ischemia.
METHODS: Patients with angina and nonobstructive coronary artery disease had 
simultaneous coronary pressure and flow velocity measured using a dual sensor-tipped 
guidewire during rest, supine bicycle exercise, and adenosine-mediated hyperemia. 
Microvascular resistance (MR) was calculated as coronary pressure divided by flow 
velocity. Wave intensity analysis quantified the proportion of accelerating wave energy 
(perfusion efficiency). Global myocardial blood flow and subendocardial:subepicardial 
perfusion ratio were quantified using 3-Tesla cardiac magnetic resonance 
imaging during hyperemia and rest; inducible ischemia was defined as hyperemic 
subendocardial:subepicardial perfusion ratio <1.0. Patients were classified as having 
MVD if coronary flow reserve <2.5 and controls if coronary flow reserve ≥2.5, with 
researchers blinded to the classification.
RESULTS: Eighty-five patients were enrolled (78% female, 57±10 years), 45 (53%) 
were classified as having MVD. Of the MVD group, 82% had inducible ischemia 
compared with 22% of controls (P<0.001); global myocardial perfusion reserve 
was 2.01±0.41 and 2.68±0.49 (P<0.001). In controls, coronary perfusion efficiency 
improved from rest to exercise and was unchanged during hyperemia (59±11% vs 
65±14% vs 57±18%; P=0.02 and P=0.14). In contrast, perfusion efficiency decreased 
during both forms of stress in MVD (61±12 vs 44±10 vs 42±11%; both P<0.001). 
Among patients with a coronary flow reserve <2.5, 62% had functional MVD, with 
normal minimal MR (hyperemic MR<2.5 mmHg/cm/s), and 38% had structural MVD 
with elevated hyperemic MR. Resting MR was lower in those with functional MVD 
(4.2±1.0 mmHg/cm/s) than in those with structural MVD (6.9±1.7 mmHg/cm/s) or 
controls (7.3±2.2 mmHg/cm/s; both P<0.001). During exercise, the structural group 
had a higher systolic blood pressure (188±25 mmHg) than did those with functional 
MVD (161±27 mmHg; P=0.004) and controls (156±30 mmHg; P<0.001). Functional 
and structural MVD had similar stress myocardial perfusion and exercise perfusion 
efficiency values.
CONCLUSION: In patients with angina and nonobstructive coronary artery disease, 
diminished coronary flow reserve characterizes a cohort with inducible ischemia and 
a maladaptive physiological response to exercise. We have identified 2 endotypes of 
MVD with distinctive systemic vascular responses to exercise; whether endotypes have 
a different prognosis or require different treatments merits further investigation.
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More than 40% of patients with angina have nonobstructive coronary artery disease (NO-CAD); the physiological basis of their symp-
toms remains elusive, and most are offered no specific 
therapy beyond reassurance.1–3 Coronary microvascular 
dysfunction (MVD), defined by diminished coronary 
flow reserve (CFR) in response to a pharmacological va-
sodilator, affects a large proportion of these patients 
and portends an increased risk of major adverse car-
diovascular events.4–7 Augmentation of coronary blood 
flow in response to increased myocardial oxygen de-
mand is achieved by vasodilation of resistance vessels, 
mediated by both endothelium-dependent and endo-
thelium-independent mechanisms.8,9 Adenosine causes 
endothelium-independent vasodilation of most vascu-
lar beds, including the coronary circulation, and is the 
most common test used to diagnose MVD. However, 
patients with MVD manifest symptoms during physio-
logical exercise, a process distinct from pharmacological 
vasodilatation. Using the technique of wave intensity 
analysis, which provides directional, quantitative, and 
temporal information on the waves that govern coro-
nary flow, pharmacological stress and exercise have 
been shown to act in fundamentally different ways.10 
Furthermore, during exercise, intramural compression is 
not uniform across the left ventricle (LV) with the sub-
endocardial layer subjected to the highest pressure, as-
sociated with the greatest impedance. In patients with 
angina and NOCAD, subendocardial hypoperfusion 
during vasodilator stress correlates with ischemic symp-
toms and is used to identify the presence of inducible 
ischemia in this cohort.11
We addressed the hypothesis that MVD (defined as 
CFR <2.5) is associated with demonstrable ischemia 
and abnormal coronary physiology during exercise. We 
also explored the pathophysiological mechanisms of at-
tenuated flow reserve in MVD.
METHODS
The data that support the findings of this study are available 
from the corresponding author on reasonable request.
Study Population
Patients undergoing elective diagnostic angiography for 
investigation of exertional chest pain were enrolled in the 
study (Figure 1). Inclusion criteria were preserved LV systolic 
function (ejection fraction >50%) and unobstructed coro-
nary arteries (<30% diameter stenosis and/or fractional flow 
reserve >0.80). Exclusion criteria were intolerance to adenos-
ine, chronic kidney disease (estimated glomerular filtration 
rate <30 mL/min/m2), concomitant valve disease (greater than 
mild on echocardiography), recent acute coronary syndrome, 
cardiomyopathy, or any neuromuscular comorbidity that may 
affect their ability to perform bicycle exercise. Antianginal 
medications were stopped, and patients abstained from caf-
feine 24 hours before all study visits. Subjects gave written 
informed consent in accordance with the protocol approved 
by the UK National Research Ethics Service (17/LO/0203). The 
study was registered with the National Institute for Health 
Research UK Clinical Research Network portfolio database 
(Central Portfolio Management System identifier: 33170).
Catheterization Protocol
Catheterization was performed through the right radial artery 
using standard coronary catheters. All patients received 1 mg 
intravenous midazolam and intraarterial unfractionated heparin 
(70 U/kg) before intracoronary physiological measurements. A 
dual-pressure and Doppler sensor-tipped 0.014-inch intracoro-
nary wire (Combowire, Philips Volcano, California) was used to 
measure distal coronary pressure and average peak flow velocity 
in the left anterior descending artery, as previously described.10 
Hemodynamic measurements were recorded under resting 
conditions, during intravenous adenosine-mediated hyperemia 
(140 mcg/kg/min) and continuously during bicycle exercise, 
using a specially adapted supine ergometer (Ergosana, Bitz, 
Germany) attached to the catheter laboratory table (Figure 2). 
Exercise began at a workload of 30 W and increased every 2 
min by 20 W. Where muscle weakness restricted increasing 
workloads, resistance was fixed at the maximum tolerated level 
and exercise continued until exhaustion. After full recovery from 
exercise or hyperemia, a second set of resting hemodynamic 
data was acquired before the final condition.
Analysis of Coronary Physiological Data
Signals were sampled at 200 Hz, with data exported into 
a custom-made study manager program (Academic Medical 
Clinical Perspective
What Is New?
• In patients with angina without obstructive coronary 
artery disease, diminished coronary flow reserve in 
response to pharmacological vasodilatation identi-
fies those with a maladaptive physiological response 
to exercise and global myocardial ischemia.
• There are 2 distinct endotypes of microvascular 
dysfunction: functional and structural, with differ-
ing degrees of systemic disease involvement and 
distinct mechanisms of ischemia.
What Are the Clinical Implications?
• Patients with angina and nonobstructive coronary 
artery disease can have exercise pathophysiology 
and global myocardial ischemia; the measurement 
of coronary flow reserve will help to characterize 
this population.
• Not all microvascular dysfunction is mechanistically 
identical; distinct endotypes may have differing 
prognosis and warrant individualized therapies.
• Targeting specific mechanistic abnormalities may 
improve the poorer prognosis observed in this pop-
ulation and would need to be studied in therapeu-
tic trials.
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Centre, University of Amsterdam, Netherlands) and analyzed 
on custom-made software, Cardiac Waves (Kings College 
London, UK). Microvascular resistance (MR) was calculated 
as distal coronary pressure divided by flow velocity for each 
condition. Hyperemic MR was dichotomously classified as 
normal (< 2.5 mmHg/cm/s) or elevated ≥2.5 mmHg/cm/s.12 
Wave intensity was calculated as the product of the deriva-
tives of distal coronary pressure and flow velocity, each 
with respect to time (d(distal coronary pressure)/dt × d(flow 
velocity)/dt), and wave separation performed as previously 
described.13 For each patient, 4 dominant waves were identi-
fied and included in our analysis: (1) backward compression 
wave (BCW), causing flow deceleration during isovolumetric 
contraction in early systole; (2) forward compression wave, 
causing flow acceleration, associated with peak aortic pres-
sure; (3) forward expansion wave, causing flow deceleration 
associated with the fall in aortic pressure in late systole; and 
(4) backward expansion wave (BEW), causing flow accel-
eration during isovolumetric relaxation in early diastole. 
Perfusion efficiency was calculated as the percentage of 
accelerating wave intensity in relation total wave intensity, 
using areas under the respective curves.
Patients were classified offline as controls or more cor-
rectly as having normal CFR (CFR ≥2.5) and MVD (CFR <2.5) 
with researchers blinded to this classification throughout the 
study protocol.
High-Resolution Cardiac Magnetic 
Resonance Imaging Protocol
All scans were performed on a dedicated 3-Tesla cardia mag-
netic resonance (CMR) scanner (Achieva, Philips Healthcare, 
Netherlands). Contiguous short-axis slices were acquired 
from the base to the apex to calculate LV function and 
mass (CVI42, v5.1.1, Circle Cardiovascular Imaging, Calgary, 
Ontario, Canada). After 3 minutes of intravenous adenos-
ine (140 mcg/kg/min), stress perfusion data were acquired 
in 3 short-axis slices using a saturation-recovery k-t sensitiv-
ity encoding accelerated gradient-echo method.14 A dual-
bolus gadobutrol (Gadovist, Bayer, Berlin, Germany) contrast 
agent scheme was used to correct for signal saturation of 
the arterial input function as previously described.15 Resting 
perfusion imaging was performed 15 minutes after stress, 
before acquisition of late gadolinium enhancement imag-
ing (total contrast agent dose 0.2 mmol/kg).16 A proton 
density acquisition was performed before stress and rest 
acquisitions to correct for spatial inhomogeneities of surface 
coils.17 Before quantitative analysis, the perfusion images 
Figure 1. Study screening criteria and tests. 
Screening, and final study enrolment (left). Test completion for 85 patients enrolled into the study (right). Cath Lab Exercise indicates catheter laboratory supine 
bicycle exercise; CFR, coronary flow reserve; CMR, cardiac magnetic resonance imaging; and NOCAD, nonobstructive coronary artery disease.
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were motion corrected according to published methods.18 
Quantitative analysis was performed as previously described 
by Fermi-constrained deconvolution.19 Myocardial blood flow 
estimates (MBF) were quantified in ml/min/g during rest and 
hyperemic stress; myocardial perfusion reserve was defined 
as the ratio between stress and rest perfusion. Endocardial-
to-epicardial-perfusion ratios were calculated during hyper-
emic stress and during rest, by dividing stress MBF estimates 
within the inner and outer layers of myocardium. Inducible 
ischemia was defined as endocardial-to-epicardial perfusion 
ratio <1.0 during hyperemia (subendocardial relative hypo-
perfusion during pharmacological vasodilation).11
NT-proBNP (N-terminal pro-B-type natriuretic peptide) lev-
els were measured before angiography using conventional 
clinical assays. Diastolic function was assessed using standard 
transthoracic echocardiography.
Statistical Analyses
Sample size was estimated on the basis of the coprimary end 
points, exercise perfusion efficiency and frequency of isch-
emia. Assuming an allocation ratio of 1:1, 66 patients would 
be needed to detect a minimum difference in exercise perfu-
sion efficiency of 12% (predicted SD, 17%) and 58 patients 
to detect a 50% relative decrease in the frequency of isch-
emia (predicted rate in MVD, 70%) at 80% power and 5% 
significance. To allow for potentially unequal allocation, data 
censoring as a result of quality issues, and incomplete data-
sets, we aimed to enroll 85 patients. Statistical analysis was 
performed using SPSS version 24 (IBM Corp., Armonk, New 
York). Normality of data was visually assessed (using histo-
grams and the normal Q-Q plot) and using the Shapiro–Wilk 
test. Continuous normal data are expressed as mean±SD and 
compared using paired or unpaired Student t tests as appro-
priate. Nonnormal data are expressed as median±interquartile 
range and compared using Mann–Whitney U test, and cat-
egorical variables were compared with chi-square tests. Two-
sided P-values <0.05 were considered nominally significant, 
with no correction for multiplicity of testing. Baseline variables 
found to correlate with exercise perfusion efficiency or induc-
ible ischemia on univariate analysis (P<0.05) were assessed by 
a multiple linear regression model.
RESULTS
Patient Characteristics
Eighty-five patients were recruited into the study (45 
were classified as having MVD and 40 had normal CFR). 
Groups were well-matched for cardiovascular risk fac-
tors and preprocedural medications, whereas there 
were more women in the MVD group (87% vs 68%; 
P=0.03) (Table 1). All patients had resting and hyper-
emic coronary physiology measurements, 68 patients 
performed the full bicycle exercise protocol, and 65 un-
derwent the 3-Tesla perfusion CMR protocol (Figure 1). 
The MVD and normal CFR groups exercised for the 
same duration (394±109 vs 408±146 s; P=0.67) and 
workload (63±27 vs 71±27 W; P=0.25).
Coronary Hemodynamic Data
CFR was 1.9±0.3 in the MVD group and 3.2±0.6 in the 
normal CFR group, with minimal epicardial disease in both 
groups (fractional flow reserve 0.92±0.05 vs 0.93±0.05, 
P=0.24). At rest, patients with MVD had reduced MR 
compared with those with normal CFR (5.3±1.9 vs 
7.3±2.2 mmHg/cm/s; P<0.001) and higher resting cor-
onary blood flow velocity (22.3±6.9 vs 15.0±4.7 cm/s; 
P<0.001) despite similar rate-pressure product between 
both groups (11 781±2929 vs 10 720±2634 bpm.mmHg; 
P=0.12). However, MR was similar in both groups during 
each form of stress (during exercise, 4.5±1.7 vs 4.7±1.6 
mmHg/cm/s; P=0.49; during hyperemia, 2.4±0.8 vs 
2.1±0.5 mmHg/cm/s; P=0.10).
Figure 2. Catheter laboratory set up during ex-
perimental exercise protocol.  
The patient is cycling whilst catheterized via the right 
radial artery with the Combowire in the left anterior 
descending artery. The Combomap console (lower) 
is displaying continuous coronary pressure and flow 
velocity.
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By wave intensity analysis, both groups had similar 
profiles at rest. During exercise and hyperemia, the mag-
nitude of all waves increased from rest, although the 
relative changes in accelerating and decelerating waves 
was significantly different in the 2 groups. Typical coro-
nary pressure and flow waveforms, with corresponding 
wave intensity analysis profiles during peak exercise, are 
shown in Figure 3. In those with normal CFR, perfusion 
efficiency was enhanced during exercise (from 59±11% 
to 65±14%; P=0.02) and remained unchanged during 
hyperemia (57±18%; P=0.14) (Figure 4a). In contrast, in 
patients with MVD, perfusion efficiency decreased from 
rest (61±12%), during peak exercise (44±10%) and hy-
peremia (42±11%; P<0.001 for both conditions). The 
difference between normal CFR and MVD groups was 
mainly in the microcirculation-derived backward waves 
rather than in the aorta-derived forward waves; at peak 
exercise, patients with MVD had proportionately larger 
decelerating BCW (36±11 vs 24±12%; P<0.001) and 
smaller accelerating BEW (30±6 vs 46±12%; P<0.001) 
than did those with normal CFR (Figure 4b).
Perfusion CMR
Sixty-eight patients attended for 3-Tesla CMR and 65 
(38 with MVD, 27 with normal CFR) underwent the 
full protocol (3 were claustrophobic, preventing exam 
completion). MVD and normal CFR groups had similar 
LV ejection fraction (66±5% vs 64±6%; P=0.33) and 
indexed mass (41±11 vs 42±19 g/m2; P=0.77). There 
was no fibrosis or scar identified during late gadolinium 
enhancement in any patient. Patients with MVD had a 
lower myocardial perfusion reserve than did those with 
normal CFR (2.01±0.42 vs 2.66±0.42; P<0.001) and 
higher resting MBF (1.37±0.37 vs 1.13±0.20 ml/min/g; 
P=0.004). Stress MBF was similar between patients 
with MVD and patients with normal CFR (2.68±0.71 
vs 2.98±0.54 ml/min/g; P=0.08). Patients with MVD 
had a lower stress endocardial-to-epicardial-perfusion 
ratio than did those with normal CFR (0.93±0.08 vs 
1.05±0.11; P<0.001). As dichotomously predefined, 
the incidence of inducible ischemia was significantly 
higher in patients with MVD than in patients with nor-
mal CFR (82% vs 22%; P<0.001; Table 2).
Pathophysiological MVD Endotypes
Among the MVD cohort, 62% had functional MVD 
with normal minimal (hyperemic) MR, and 38% had 
structural MVD with elevated hyperemic MR. Patients 
with structural MVD had a higher incidence of hyper-
tension and diabetes mellitus compared with patients 
with functional MVD (76% vs 43%; P=0.03; and 47% 
vs 18%; P=0.04). In patients with functional MVD, 
resting MR was reduced compared with patients with 
structural MVD and patients with normal CFR (4.2±1.0 
vs 6.9±1.7 vs 7.3±2.2 mmHg/cm/s; P<0.001 for both). 
In patients with structural MVD, hyperemic MR was 
higher than in patients with normal CFR and patients 
with functional MVD (3.1±0.7 vs 2.1±0.5 vs 1.9±0.4 
mmHg/cm/s; P<0.001 for both; Figure 5). Patients with 
normal CFR had a larger reduction in MR during exercise 
and hyperemia (2.9±2.0 and 5.3±2.1 mmHg/cm/s) than 
did structural MVD (0.8±1.0 and 3.2±1.1 mmHg/cm/s; 
P<0.001 for both) and functional MVD (0.8±1.0 and 
2.4±1.0 mmHg/cm/s; P<0.001 for both) endotypes. In 
terms of external work, during peak exercise, the struc-
tural MVD group had a higher systolic blood pressure 
(188±2 5mmHg) than did the functional MVD (161±27 
mmHg; P=0.004) and the normal CFR group (156±30 
mmHg; P<0.001) and a higher rate-pressure product 
(22 157±5497 vs 19 519±4653 vs 17 530±4678 bpm.
mmHg; P=0.12 vs functional and P=0.004 vs normal 
CFR; Figure 5). Perfusion efficiency during exercise and 
hyperemia were similar in patients with functional and 
structural MVD (46±9% vs 41±10% and 41±12% vs 
44±9%; P=0.12 and P=0.31, respectively). Functional 
and structural MVD had similar myocardial perfusion 
reserve and stress endocardial-to-epicardial-perfusion 
ratio (2.01±0.41 vs 2.05±0.44; P=0.78; and 0.94±0.10 
vs 0.93±0.05; P=0.66). The rate of inducible ischemia 
was numerically lower in functional MVD versus struc-
tural MVD, but this difference was not statistically sig-
nificant (77% vs 88%; P=0.42).
NT-proBNP value was highest in patients with struc-
tural MVD compared with patients with functional MVD 
and patients with a normal CFR (132 [82–179] vs 69 
Table 1. Patient Characteristics and Long-Term Medication Before 
Angiography
Normal 
Coronary Flow 
Reserve (n=40)
Microvascular 
Dysfunction 
(n=45) P Value
Demographics
  Female 27 (68) 39 (87) 0.03
  Age, y 57±10 57±11 0.89
  Hypertension 25 (63) 25 (56) 0.52
  Diabetes mellitus 9 (23) 13 (29) 0.50
  Hypercholesterolemia 22 (55) 24 (53) 0.88
  Smoker 13 (33) 12 (27) 0.56
Medication before angiography
  Aspirin 16 (40) 14 (31) 0.47
  Statin 23 (51) 19 (48) 0.32
  ACE inhibitor/ARB 11 (28) 12 (27) 0.67
  β-blocker 13 (33) 10 (22) 0.42
  Calcium channel blocker 13 (33) 15 (33) 0.76
  No. of antianginals 0.9±0.9 0.8±0.8 0.63
  No. of antihypertensives 0.5±0.6 0.7±0.9 0.21
Values are n (%) or mean±SD. ACE indicates angiotensin-converting enzyme; 
and ARB, angiotensin receptor blocker.
D
ow
nloaded from
 http://ahajournals.org by on December 17, 2019
Rahman et al Exercise Physiology in Microvascular Dysfunction
November 26, 2019 Circulation. 2019;140:1805–1816. DOI: 10.1161/CIRCULATIONAHA.119.0415951810
OR
IG
IN
AL
 R
ES
EA
RC
H 
AR
TI
CL
E
[32–116] vs 34 [22–90] pg/ml; P=0.01 and P<0.001). 
Diastolic function measured by echocardiography tissue 
Doppler e/e’ was similar between structural MVD, func-
tional MVD and patients with normal CFR (8.4±2.3 vs 
7.5±3.0 vs 6.9±2.2; P=0.39 and P=0.07).
The pathophysiological changes of diminished 
coronary flow reserve in NOCAD are summarized in 
Figure 6.
DISCUSSION
This is the first study to directly assess coronary blood 
flow during exercise in patients with microvascular dys-
function and compare these changes with high-reso-
lution perfusion imaging. Among patients with angina 
and unobstructed coronary arteries, those with dimin-
ished coronary flow reserve have a higher prevalence of 
inducible myocardial ischemia and reduced global per-
fusion reserve in addition to reduced coronary perfusion 
efficiency during physical exercise compared with con-
trols with preserved coronary flow reserve. We distin-
guished 2 microvascular dysfunction endotypes, those 
with low resting microvascular resistance (functional) 
and those with high minimal microvascular resistance 
(structural), both displaying similar myocardial perfusion 
characteristics and distinct exercise pathophysiology. 
The relationship with diminished  coronary  vasodilator 
reserve and these pathophysiological changes may un-
derlie the poorer prognosis exhibited by patients with 
microvascular dysfunction and whether each endotype 
warrants individualized therapies will need to be stud-
ied further.
Diminished Flow Reserve
The historical perception of MVD is that high vascular 
resistance during periods of increased demand or phar-
macological vasodilatation is the key mechanistic ab-
normality. This structural MVD endotype may represent 
architectural changes such as capillary rarefaction and 
downstream myocardial hypertrophy and fibrosis. In-
deed, there are several physiological parallels with heart 
failure with preserved ejection fraction, where coronary 
blood flow is elevated during rest and similarly dimin-
ished during vasodilator hyperemia.20 However, this state 
of raised minimal MR may be surmountable over time 
with appropriate treatment and so the term structural 
should not be considered to imply an irreversible disease 
process. Many authors have suggested that high mini-
mal microvascular resistance is a more reliable tool for 
identification of patients with MVD and that this should 
replace measurements such as CFR, where resting con-
ditions are integrated particularly in a population where 
there is mixed epicardial artery disease.21 However, in 
Figure 3. Two examples of wave intensity analysis during peak exercise in a control patient with normal coronary flow reserve (CFR) (left) and 
microvascular dysfunction (MVD) patient (right).  
Ensemble averaged aortic pressure (top, light blue), coronary pressure (top, dark blue), flow velocity (top red) and wave intensity analysis (bottom). BCW indicates 
backward compression wave; BEW, backward expansion wave; and FCW, forward compression wave.
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our NOCAD population, 62% of patients with MVD 
had preserved minimal MR (or functional MVD) despite 
a diminished CFR, yet they displayed a similar pathologi-
cal phenotype as the traditional structural MVD group. 
The finding of low resting MR suggests that this is a 
functional disorder rather than being primarily the re-
sult of structural vascular changes leading to elevated 
minimal MR. This is consistent with recent observations 
by other groups where elevated myocardial and coro-
nary blood flow was the likely mechanism of diminished 
flow reserve in MVD.22,23 In this context, elevated rest-
ing flow could be a response to increased myocardial 
oxygen demand or represent disordered autoregulation. 
We did not find a statistically significant difference in 
mechanical cardiac work at rest, as estimated by rate-
pressure product, but it should be noted that myocar-
dial oxygen demand is also dependent on basal meta-
bolic activity and calcium cycling.24 High baseline MBF 
has been proposed to be due to increased myocardial 
oxygen consumption secondary to myocardial metabolic 
derangements, in studies of patients fitting the historical 
Cardiac Syndrome X definition.25–27 Diminished flow re-
serve in patients with diabetes mellitus has been shown 
to be due to elevated resting flow in the early stages of 
the disease.22 This may be a response to increased basal 
oxygen consumption as the metabolic shift in diabetics, 
from glucose to fatty acid oxidation, results in fewer ATP 
molecules produced per molecule of oxygen consumed; 
this theory would need to be explored further in MVD. 
While increased resting flow can lead to a reduction in 
vasodilator capacity, it may also play a role in disease 
progression. Chronically raised coronary blood flow may 
precipitate structural vascular changes, a process com-
monly found in other organs, such as the renal or pul-
monary vascular beds.28,29 This may also explain the bi-
modal distribution of microvascular resistance found in 
patients with diabetes mellitus, with an early functional 
disorder progressing to structural changes.22 Whether 
functional MVD represents a precursor to structural 
MVD and early intervention may prevent disease pro-
gression is currently unknown. At present, no disease-
modifying therapies exist specifically for MVD.
The Mechanism of Ischemia
Within the structural MVD group, exercise-induced 
hypertension leads to increased myocardial oxygen 
Figure 4. Coronary wave intensity analysis during stress. 
(A) During exercise, microvascular dysfunction (MVD) patients have a smaller proportion backward expansion wave (BEW) and greater proportion of backward 
compression wave (BCW) energy than patients with normal coronary flow reserve (CFR). *P<0.001. (B) In patients with MVD, the total percentage of accelerating 
wave intensity decreases in response to exercise and during vasodilator mediated hyperemia (reduced coronary perfusion efficiency) from rest; in those with normal 
CFR, coronary perfusion efficiency remains unchanged during exercise or hyperemia from resting conditions (*P<0.05).
Table 2. Results From Quantitative Perfusion Cardiac Magnetic 
Resonance Imaging
Control 
(n=27)
Microvascular 
Dysfunction 
(n=38) P Value
Global perfusion
  Rest myocardial blood flow 1.13±0.20 1.37±0.37 0.004*
  Stress myocardial blood flow 2.98±0.54 2.68±0.71 0.08
  Myocardial perfusion reserve 2.68±0.49 2.01±0.41 <0.001*
Global endo/epi ratio
  Endo/epi rest 1.01±0.03 1.00±0.01 0.08
  Endo/epi stress 1.05±0.11 0.93±0.08 <0.001*
  Inducible ischemia 6 (22) 31 (82) <0.001*
Segmental endo/epi during stress
  Endo/epi basal 1.04±0.13 0.93±0.11 0.001*
  Endo/epi mid 0.99±0.12 0.90±0.08 0.001*
  Endo/epi apex 1.07±0.13 0.98±0.11 0.003*
Values are n (%) or mean±SD. Basal, mid, and apex refer to left ventricular 
location. Induced ischemia is defined as stress endo/epi <1.0. Endo/epi indicates 
subendocardium-to-subepicardium blood flow ratio.
*P<0.05.
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 demand during exercise. Attenuated reduction in after-
load with exercise would interrupt the usual synergistic 
response of the coronary and peripheral circulations and 
predispose to ischemia; in theory, large vessel vasodila-
tors may enhance the normal synergistic adaptation to 
exercise preferentially among this disease endotype.30 
The structural MVD group have more established car-
diovascular risk factors and poorly controlled hyper-
tension, a process similarly associated with diminished 
maximal flow.31
In functional MVD, minimal microvascular resis-
tance during stress is preserved compared with those 
with preserved CFR; therefore, this measurement can-
not account for the ischemic changes identified dur-
ing perfusion imaging. Wave intensity analysis provides 
unique insight into cardiac-coronary coupling among 
both MVD endotypes. Whereas coronary perfusion ef-
ficiency increases or is maintained with exercise and 
hyperemia in the healthy heart, in MVD perfusion ef-
ficiency decreases with both forms of stress.10 Reduced 
perfusion efficiency in MVD demonstrates that greater 
energy needs to be expended to achieve the same de-
gree of coronary blood flow augmentation, providing 
an ischemic substrate in both functional and structural 
MVD groups. The decreased perfusion efficiency with 
exercise in MVD is primarily determined by attenuated 
augmentation of the BEW, which is usually the main 
driver of coronary perfusion in health. The BEW is gen-
erated during ventricular lusitropy, thus flow accel-
eration will be diminished when there is diastolic dys-
function.32 Conversely, subendocardial hypoperfusion 
results in diastolic dysfunction, while transmural hypo-
perfusion results in overt systolic and diastolic dysfunc-
tion.33 While establishing causality remains challenging 
because of the intricate interplay of these parameters, 
exercise induced diastolic dysfunction and ischemia will 
amplify each other in a potentially deleterious cycle. In 
our study, both patient groups had similar resting di-
astolic function in terms of resting echocardiography 
while a trend toward increasing NT-proBNP values from 
Figure 5. Coronary and systemic hemodynamic responses to stress.  
Time points are 1 minute after onset of exercise, 50% of maximal exercise time and peak (immediately before termination of exercise). White area denotes physi-
cal exercise, gray area denotes pharmacological hyperemia. bpm indicates beats per minute; CFR, coronary flow reserve; hyperemia, adenosine-induced hyperemia; 
and MVD, microvascular dysfunction.
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patients with normal CFR, to functional MVD and struc-
tural MVD may support the notion of temporal progres-
sion of MVD disease states.
During systole, compression of the subendocardi-
um causes retrograde filling of the subepicardial ves-
sels, therefore antegrade subendocardial filling occurs 
exclusively in diastole. Myocardial oxygen demand is 
increased in the subendocardium, increased vascula-
ture within this layer ensures perfusion is maintained 
throughout the cardiac cycle and indeed in health, 
pharmacological vasodilatation maintains hyperperfu-
sion within the subendocardial layer.34 We have dem-
onstrated a reduction in coronary perfusion efficiency 
during vasodilator hyperemia in MVD, accentuation 
of the BCW and attenuation of the BEW will dispro-
portionately affect subendocardial blood flow. Loss of 
privileged perfusion of this layer in MVD may be the 
driving force behind subendocardial ischemia leading 
to diastolic dysfunction and inefficient coronary per-
fusion during exercise. Myocardial  contraction in the 
Figure 6. Coronary flow reserve (CFR) measurement in patients with angina and nonobstructive coronary artery disease (NOCAD).  
Low CFR can arise via 2 distinct microvascular dysfunction endotypes, classified using hyperemic microvascular resistance. Functional and structural microvascular 
dysfunction (MVD) endotypes have differing degrees of systemic disease involvement, however both display reduced coronary perfusion efficiency during stress 
and higher rates of global myocardial ischemia compared with controls with normal CFR.
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face of higher vascular resistance within the suben-
docardial layer may also account for the exaggerated 
BCW during isovolumetric contraction, while con-
versely a larger BCW can diminish systolic perfusion. 
Indeed, the mechanics of image acquisition during 
perfusion CMR whereby the basal-, mid-, and apical-
LV slices are acquired during mid-diastole, mid-systole, 
and late-diastole, respectively, demonstrates that sub-
endocardial perfusion in MVD is impaired throughout 
the cardiac cycle (Table 2). The ability of the coronary 
microvasculature to dilate during periods of stress 
seems pivotal to preventing the maladaptive changes 
to exercise and myocardial perfusion observed within 
the MVD cohort. With therapies shown to improve 
outcome in patients with MVD as defined by low CFR, 
further work will need to be carried out to determine 
whether the distinct functional and structural MVD 
endotypes should be managed differently.35,36
Coronary Flow Reserve and Inducible 
Ischemia
The Coronary Vasomotion Disorders International 
Study Group agreed upon the following criteria for 
the diagnosis of microvascular angina: (1) presence 
of symptoms suggestive of myocardial ischemia; (2) 
objective documentation of myocardial ischemia; (3) 
absence of obstructive CAD >50% coronary diameter 
reduction and/or fractional flow reserve >0.80); and 
(4) confirmation of a reduced coronary blood flow re-
serve and/or inducible microvascular spasm.37 We have 
demonstrated that a CFR<2.5 (in our NOCAD cohort) 
accurately predicted myocardial ischemia and exercise 
pathophysiology. Emerging data suggests that a bi-
nary CFR threshold of 2.5 more accurately identifies 
patients with MVD than the less sensitive value of 2.0, 
both currently accepted by international guideline 
committees and experts within the field.37–40 Whether 
a CFR<2.5 alone is sufficient to diagnose MVD (when 
noninvasive ischemia testing has not been performed) 
is something the guideline committees may wish to 
consider, but in the meantime this study should pro-
vide clinicians with a strong recommendation to per-
form invasive coronary physiology in patients who 
undergo cardiac catheterization. Recent studies have 
also demonstrated the correlation between global 
measurements of myocardial perfusion and invasive 
coronary functional testing.41 Within our study, 22% 
of patients with normal vasodilator reserve demon-
strated inducible ischemia on quantitative perfusion 
imaging, and this group of patients may have other 
ischemic pathologies. One explanation is that CFR in-
tegrates epicardial and endocardial blood flow within 
a given territory; good perfusion in the former may 
mask ischemia affecting the latter.
Study Limitations
This was a mechanistic single-center study with rela-
tively small numbers of patients in each group. The lack 
of correction for multiplicity increases the possibility for 
type 1 error for each of the analyses presented. Invasive 
CFR is currently the most accepted method for classi-
fying MVD in patients with NOCAD. Like all biological 
measurements, CFR is a continuous variable and for this 
study a dichotomous CFR threshold of 2.5 was adopted 
to define MVD, acknowledging that a lower threshold 
may have had enhanced specificity at the cost of sensitiv-
ity. Moreover, given that our control group consisted of 
patients who were not healthy volunteers but who had 
symptoms that had led to angiography, we adopted a 2.5 
threshold to ensure that their endothelium-independent 
microvascular function was truly normal. Indeed, pa-
tients in the control group may have occult coronary ab-
normalities such as endothelial dysfunction or coronary 
vasospasm that could be unmasked during provocation 
testing. The study was powered to detect differences in 
exercise and myocardial perfusion physiology between 
patients with preserved CFR and diminished CFR, not 
among MVD endotypes. A larger sample size may have 
enabled the identification of differences between the 2 
endotypes. A normal hyperemic microvascular resistance 
value is currently undefined in a NOCAD population be-
cause of the absence of a gold standard measure to as-
sess microvascular function in vivo. However, our study 
describes 2 distinct endotypes with differing degrees of 
systemic disease involvement based around a 2.5 mmHg/
cm/s value. We were not able to directly assess myocar-
dial perfusion during exercise in this study; therefore, we 
were unable to demonstrate exercise-induced ischemia 
per se, although vasodilator mediated perfusion hetero-
geneity during CMR is widely regarded as a surrogate 
of ischemia in routine clinical practice. Subendocardial 
hypoperfusion during hyperemia represents a very early 
stage of the ischemic cascade and so its presence may 
not correlate perfectly with later stages, such as wall 
motion abnormalities. However, this is a widely adopted 
index for identifying the presence of inducible ischemia, 
particularly in a NOCAD population and is strongly rec-
ommended in practice guidelines. Because of the length 
of this protocol, not all study patients underwent CMR; 
however, this was factored into the study design and sta-
tistical power calculation.
CONCLUSION
Patients with MVD, defined by diminished vasodilator 
reserve in the cardiac catheter laboratory, have induc-
ible ischemia and inefficient coronary perfusion dur-
ing exercise. These findings are consistent among the 
2 distinct MVD endotypes, defined by either abnormal 
resting or minimal microvascular resistances and reflect 
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differing degrees of systemic disease involvement. Pre-
served coronary vasodilatory reserve is pivotal to normal 
exercise physiology and myocardial perfusion; reduced 
CFR may lead to poorer clinical outcomes in patients 
with angina and NOCAD through these pathophysi-
ological changes. Whether each endotype exhibits a 
different prognosis or requires distinct therapies merits 
further investigation.
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